K24 CA093670/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2007	2
2008	5
2009	3
2010	3
2011	9
2012	3
2013	1
2014	3
2015	2
2016	7
2017	2
2018	3
2019	2
2020	1
2021	1
2024	0

1

Observations on the use of Bruton's tyrosine kinase inhibitors in SAR-CoV-2 and cancer.

Benner B, Carson WE. Benner B, et al. J Hematol Oncol. 2021 Jan 13;14(1):15. doi: 10.1186/s13045-020-00999-8. J Hematol Oncol. 2021. PMID: 33441177 Free PMC article.

2

Tissue microRNA expression profiling in hepatic and pulmonary metastatic melanoma.

DiVincenzo MJ, Latchana N, Abrams Z, Moufawad M, Regan-Fendt K, Courtney NB, Howard JH, Gru AA, Zhang X, Fadda P, Carson WE. DiVincenzo MJ, et al. Melanoma Res. 2020 Oct;30(5):455-464. doi: 10.1097/CMR.0000000000000692. Melanoma Res. 2020. PMID: 32804708 Free PMC article.

3

Evidence for interaction of the NLRP3 inflammasome and Bruton's tyrosine kinase in tumor-associated macrophages: implications for myeloid cell production of interleukin-1beta.

Benner B, Scarberry L, Stiff A, Duggan MC, Good L, Lapurga G, Butchar JP, Tridandapani S, Carson WE. Benner B, et al. Oncoimmunology. 2019 Sep 5;8(11):1659704. doi: 10.1080/2162402X.2019.1659704. eCollection 2019. Oncoimmunology. 2019. PMID: 31646085 Free PMC article.

4

An IL-15-based superagonist ALT-803 enhances the NK cell response to cetuximab-treated squamous cell carcinoma of the head and neck.

Pinette A, McMichael E, Courtney NB, Duggan M, Benner BN, Choueiry F, Yu L, Abood D, Mace TA, Carson WE 3rd. Pinette A, et al. Cancer Immunol Immunother. 2019 Aug;68(8):1379-1389. doi: 10.1007/s00262-019-02372-2. Epub 2019 Jul 23. Cancer Immunol Immunother. 2019. PMID: 31338557 Free PMC article.

5

Alterations in patient plasma microRNA expression profiles following resection of metastatic melanoma.

Latchana N, DiVincenzo MJ, Regan K, Abrams Z, Zhang X, Jacob NK, Gru AA, Fadda P, Markowitz J, Howard JH, Carson WE 3rd. Latchana N, et al. J Surg Oncol. 2018 Sep;118(3):501-509. doi: 10.1002/jso.25163. Epub 2018 Aug 21. J Surg Oncol. 2018. PMID: 30132912 Free PMC article.

6

Modeling combination therapy for breast cancer with BET and immune checkpoint inhibitors.

Lai X, Stiff A, Duggan M, Wesolowski R, Carson WE 3rd, Friedman A. Lai X, et al. Proc Natl Acad Sci U S A. 2018 May 22;115(21):5534-5539. doi: 10.1073/pnas.1721559115. Epub 2018 May 7. Proc Natl Acad Sci U S A. 2018. PMID: 29735668 Free PMC article.

7

Nitric Oxide Production by Myeloid-Derived Suppressor Cells Plays a Role in Impairing Fc Receptor-Mediated Natural Killer Cell Function.

Stiff A, Trikha P, Mundy-Bosse B, McMichael E, Mace TA, Benner B, Kendra K, Campbell A, Gautam S, Abood D, Landi I, Hsu V, Duggan M, Wesolowski R, Old M, Howard JH, Yu L, Stasik N, Olencki T, Muthusamy N, Tridandapani S, Byrd JC, Caligiuri M, Carson WE. Stiff A, et al. Clin Cancer Res. 2018 Apr 15;24(8):1891-1904. doi: 10.1158/1078-0432.CCR-17-0691. Epub 2018 Jan 23. Clin Cancer Res. 2018. PMID: 29363526 Free PMC article.

8

Plasma MicroRNA Levels Following Resection of Metastatic Melanoma.

Latchana N, Abrams ZB, Howard JH, Regan K, Jacob N, Fadda P, Terando A, Markowitz J, Agnese D, Payne P, Carson WE 3rd. Latchana N, et al. Bioinform Biol Insights. 2017 Feb 23;11:1177932217694837. doi: 10.1177/1177932217694837. eCollection 2017. Bioinform Biol Insights. 2017. PMID: 28469417 Free PMC article.

9

The combination of MLN2238 (ixazomib) with interferon-alpha results in enhanced cell death in melanoma.

Suarez-Kelly LP, Kemper GM, Duggan MC, Stiff A, Noel TC, Markowitz J, Luedke EA, Yildiz VO, Yu L, Jaime-Ramirez AC, Karpa V, Zhang X, Carson WE 3rd. Suarez-Kelly LP, et al. Oncotarget. 2016 Dec 6;7(49):81172-81186. doi: 10.18632/oncotarget.12791. Oncotarget. 2016. PMID: 27783987 Free PMC article.

10

Targeting myeloid-derived suppressor cells using a novel adenosine monophosphate-activated protein kinase (AMPK) activator.

Trikha P, Plews RL, Stiff A, Gautam S, Hsu V, Abood D, Wesolowski R, Landi I, Mo X, Phay J, Chen CS, Byrd J, Caligiuri M, Tridandapani S, Carson W. Trikha P, et al. Oncoimmunology. 2016 Jul 25;5(9):e1214787. doi: 10.1080/2162402X.2016.1214787. eCollection 2016. Oncoimmunology. 2016. PMID: 27757311 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

44 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year